Ledger.Open graph →
SEC Form D · filed August 21, 2015

Orbus Therapeutics, Inc

Offering
$32.5M
Sold
$18.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
APTOS, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Jason D. Levin · Aptos, CAExec · DirectorErnest D. Mario · Aptos, CADirectorMichael D. Wasserman · Aptos, CADirectorPatrick D. Enright · Aptos, CADirectorElisha (Terry) D. Gould · Aptos, CADirectorRobert M. Myers · Aptos, CAExec · DirectorJason D. Levin · San Diego, CAExec · DirectorErnest D. Mario · Aptos, CADirectorMichael D. Wasserman · Aptos, CADirectorPatrick D. Enright · Aptos, CADirectorElisha (Terry) D. Gould · Aptos, CADirectorRobert M. Myers · Aptos, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗